Proline oxidase silencing inhibits p53-dependent apoptosis in MCF-7 breast cancer cells
Proline oxidase (POX) is mitochondrial proline-degrading enzyme of dual apoptosis/survival function. POX expression and proline availability are considered an underlying mechanism for differential POX functions. The mechanism for POX-dependent regulation of cell death/survival was studied in wild-ty...
Gespeichert in:
Veröffentlicht in: | Amino acids 2021-12, Vol.53 (12), p.1943-1956 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Proline oxidase (POX) is mitochondrial proline-degrading enzyme of dual apoptosis/survival function. POX expression and proline availability are considered an underlying mechanism for differential POX functions. The mechanism for POX-dependent regulation of cell death/survival was studied in wild-type (MCF-7
WT
) and shRNA POX-silenced breast cancer cells (MCF-7
iPOX
). Proline concentration and proteomic analyses were determined by LC/MS/QTOF and LC/MS/ORBITRA, respectively. Inhibition of collagen biosynthesis (proline utilizing process) by 2-methoxyestradiol (2ME) contributed to induction of apoptosis in MCF-7
WT
cells, as detected by increase in the expression of active caspase-3, -9 and p53. The process was not shown in MCF-7
iPOX
. In MCF-7
iPOX
cells prolidase activity and expression as well as proline concentration were drastically increased, compared to MCF-7
WT
cells. Down-regulation of p53 in MCF-7
iPOX
cells was corroborated by proteomic analysis showing decrease in the expression of p53-related proteins. The mechanism for down-regulation of p53 expression in MCF-7
iPOX
cells was found at the level of p53–PEPD complex formation that was counteracted by hydrogen peroxide treatment. In this study, we found that silencing POX modulate pro-survival phenotype of MCF-7 cells and suggest that the mechanism of this process undergoes through down-regulation of p53-dependent signaling. |
---|---|
ISSN: | 0939-4451 1438-2199 |
DOI: | 10.1007/s00726-021-03013-8 |